GlaxoSmithKline Plc is right to snub Unilever Plc’s 50 billion-pound ($68 billion) proposal to buy the UK drugmaker’s consumer healthcare arm. Unilever’s offer may be in the ballpark, but the consumer-goods giant can justify stretching further — and could easily be forced to. The asset is a unique business with scale and strong brands, including Panadol painkillers and Sensodyne ...

Over the years, as social media companies gorged themselves on the data of billions of people to fuel vast profits, the information flow never went the other way. Now the tables are turning. One of the most promising pieces of legislation in Congress tackling tech giants’ undue influence, out of reportedly 30 or so bills, would force such firms to ...

  Lithuania is a small country with a big problem. After a series of perceived slights, China has brought its massive economic leverage to bear on the tiny Baltic state. Pressure increased dramatically in recent weeks after Taiwanese officials opened a de facto embassy in the Lithuanian capital using the island’s name. (The many other such offices around the world, ...